Thermo Fisher Scientific, Inc. Share Price
Equities
TMO
US8835561023
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 442.00 USD | +0.83% |
|
-2.34% | -23.72% |
| 15/05 | Thermo Fisher Likely to Benefit From End-Market Recovery, but Structural Risks Remain, RBC Says | MT |
| 14/05 | Nuvation Bio Collaborates With Thermo Fisher Scientific For Lung Cancer Treatment | DJ |
| Capitalization | 16TCr 14TCr 13TCr 12TCr 23TCr 15,82400Cr 23TCr 1,54600Cr 60TCr 7,48700Cr 62TCr 60TCr 26,09600Cr | P/E ratio 2026 * |
22x | P/E ratio 2027 * | 19.1x |
|---|---|---|---|---|---|
| Enterprise value | 20TCr 17TCr 15TCr 15TCr 27TCr 18,79900Cr 27TCr 1,83600Cr 71TCr 8,89500Cr 73TCr 72TCr 31,00300Cr | EV / Sales 2026 * |
4.08x | EV / Sales 2027 * | 3.78x |
| Free-Float |
83.29% | Yield 2026 * |
0.42% | Yield 2027 * | 0.44% |
Last Transcript: Thermo Fisher Scientific, Inc.
| 1 day | +0.83% | ||
| 1 week | -2.34% | ||
| Current month | -7.72% | ||
| 1 month | -16.07% | ||
| 3 months | -13.93% | ||
| 6 months | -23.27% | ||
| Current year | -23.72% |
| 1 week | 435.27 |  | 463.4 |
| 1 month | 435.27 | | 538.4 |
| Current year | 435.27 | | 643.99 |
| 1 year | 385.46 | | 643.99 |
| 3 years | 385.46 | | 643.99 |
| 5 years | 385.46 | | 672.34 |
| 10 years | 139.07 | | 672.34 |
| Manager | Title | Age | Since |
|---|---|---|---|
Marc Casper
CEO | Chief Executive Officer | 58 | 15/10/2009 |
Jim Meyer
DFI | Director of Finance/CFO | 46 | 01/03/2026 |
Gianluca Pettiti
PSD | President | 47 | 01/03/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Scott Sperling
BRD | Director/Board Member | 68 | 09/11/2006 |
Marc Casper
CHM | Chairman | 58 | 26/02/2020 |
Tyler Jacks
BRD | Director/Board Member | 65 | 26/05/2009 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +4.97% | 7.43% | 27 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.83% | -2.34% | +7.27% | -15.57% | 16TCr | |
| +4.46% | +4.73% | -21.94% | +40.90% | 16TCr | |
| +1.20% | -1.60% | -16.44% | -27.63% | 12TCr | |
| +6.15% | +4.78% | -47.27% | +4.64% | 8.31TCr | |
| +1.24% | +6.76% | +5.63% | -5.74% | 4.74TCr | |
| +1.02% | +0.38% | -30.86% | -36.77% | 4.37TCr | |
| +0.90% | -4.56% | -7.59% | +23.93% | 3.26TCr | |
| +0.37% | +0.58% | -1.46% | -13.19% | 3.17TCr | |
| +1.12% | +2.71% | -18.89% | -8.95% | 2.96TCr | |
| -2.52% | -7.61% | -30.93% | -49.15% | 2.78TCr | |
| Average | +0.25% | -1.25% | -16.25% | -8.75% | 7.32TCr | |
| Weighted average by Cap. | +0.03% | -0.37% | -14.83% | -2.94% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.78TCr 4.1TCr 3.76TCr 3.57TCr 6.57TCr 4,60300Cr 6.68TCr 45TCr 17TCr 2,17800Cr 18TCr 18TCr 7,59000Cr | 5.04TCr 4.33TCr 3.96TCr 3.76TCr 6.92TCr 4,85300Cr 7.04TCr 47TCr 18TCr 2,29600Cr 19TCr 19TCr 8,00300Cr |
| Net income | 733.71Cr 630.41Cr 576.8Cr 547.78Cr 1.01TCr 71TCr 1.03TCr 6.9TCr 2.68TCr 33TCr 2.75TCr 2.7TCr 1,16600Cr | 819.23Cr 703.88Cr 644.02Cr 611.62Cr 1.13TCr 79TCr 1.15TCr 7.71TCr 2.99TCr 37TCr 3.07TCr 3.01TCr 1,30200Cr |
| Net Debt | 3.09TCr 2.65TCr 2.43TCr 2.31TCr 4.25TCr 2,97600Cr 4.32TCr 29TCr 11TCr 1,40800Cr 12TCr 11TCr 4,90700Cr | 2.6TCr 2.23TCr 2.04TCr 1.94TCr 3.57TCr 2,50400Cr 3.63TCr 24TCr 9.48TCr 1,18500Cr 9.76TCr 9.55TCr 4,13000Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/26/18 | 442.00 $ | +0.83% | 19,08,610 |
| 15/26/15 | 438.34 $ | -2.20% | 20,38,091 |
| 14/26/14 | 448.21 $ | +0.49% | 21,00,472 |
| 13/26/13 | 446.03 $ | -2.89% | 28,01,576 |
| 12/26/12 | 459.30 $ | +1.48% | 30,55,857 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- TMO Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition